Lasinone 10mg Capsule contains Nitisinone, a potent inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase, used primarily in the management of hereditary tyrosinemia type 1 (HT-1). By blocking the catabolic pathway of tyrosine, Nitisinone effectively reduces the accumulation of toxic metabolites such as fumarylacetoacetate and succinylacetone, which are responsible for liver and kidney damage in affected patients. Lasinone is indicated for long-term treatment to prevent acute hepatic crises, renal dysfunction, and neurological complications associated with HT-1. The recommended dosage should be individualized based on patient response and monitored through biochemical markers, including plasma tyrosine and succinylacetone levels. Adverse effects may include elevated plasma tyrosine concentrations, ocular symptoms such as keratitis, and potential skin reactions; thus, regular ophthalmologic and clinical monitoring is advised. Lasinone should be used under strict medical supervision, and dietary management restricting tyrosine and phenylalanine intake is recommended to optimize therapeutic outcomes. It is contraindicated in patients with hypersensitivity to Nitisinone or any capsule components. Caution is warranted in pregnancy and lactation due to limited safety data. Overall, Lasinone 10mg Capsule offers a targeted therapeutic approach for HT-1, improving prognosis and quality of life in affected individuals.